))
Season 7 Episode 5 : Updates in CAR T-Cell Therapy for Multiple Myeloma
Manage episode 438235952 series 3445704
Content provided by NCODA and Ginger Blackmon. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by NCODA and Ginger Blackmon or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
In this episode, Jordan Scott, PharmD, from Roswell Park Comprehensive Cancer Center, shares insights into the latest advancements in CAR T-cell therapy for Multiple Myeloma.
This week's episode offers pharmacists the opportunity to earn 0.5 CE credit hours while exploring the newly expanded scope of CAR T-cell therapy and novel toxicities associated with specific CAR-T products. Learn effective management strategies for these toxicities and enhance patient outcomes in your practice.
Jordan earned his Doctor of Pharmacy degree from D’Youville University in 2021. He completed his PGY1 Pharmacy residency training at Buffalo General Medical Center and PGY2 Oncology Pharmacy residency training at Roswell Park Comprehensive Cancer. His areas of practice include lymphoma, multiple myeloma, and transplant/cellular therapies. He is involved in direct patient care, collaborative practice, precepting, teaching, and research. Jordan is an avid football fan, cheering on the home team in Buffalo. Go Bills!
To register for CE credit, please visit: https://www.lecturepanda.com/r/CARTOnDemand
Jordan has no relevant financial relationships to disclose.
126 episodes
Share
